Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study: Black & AA Recruitment Supplement

弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测:黑人

基本信息

  • 批准号:
    10786286
  • 负责人:
  • 金额:
    $ 25.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary This supplement seeks to explore alternative approaches to the recruitment and retention of Black American participants in AD/ADRD research utilizing digital assessments. Black Americans are underrepresented in the FHS cohort, which is predominantly non-Hispanic White. Participants who self- identify as Black represent only 1.7% of the FHS cohort, whereas they comprise 5.2% of Middlesex Country, which includes the town of Framingham and surrounding communities; this is lower than what is found within the state of Massachusetts where, the Black Americans comprise 9.3% of the total population. AD/ADRD affects Black Americans at higher rates than non-Hispanic Whites, which makes it essential that they be included in research, but recruitment efforts are limited in their success. One widely described factor making recruitment of Black Americans challenging is the lack of trust in scientific research subsequent to the historical abuse of this population by the U.S. government and scientists, and so we are centering the fostering of trust in our approach. We intend to work with two experts in Black community engagement to facilitate our efforts. Our first aim involves making connections with local Black leaders to have discussions about the needs of the community and how we can contribute to the needs so we might foster trust and collaboratively design an effective recruitment/retention protocol. The second aim is to implement and evaluate this newly developed recruitment/retention protocol by soliciting feedback from community members for whom the protocol was successful (increased interest in learning about the research) as well as from those for whom the protocol did not foster interest in engagement. We will revise the protocol based on this feedback, employ the revised procedures, and re-evaluate. The third aim is to ask those who expressed interest in learning more about our research to evaluate the digital data collection protocol and give feedback on which parts they would, and which they would not, be willing to do. They will then be invited to participate in our digital data collection study to increase representation of Black Americans. We anticipate collecting digital data from between 119-314 Black American participants.
项目摘要 本补编旨在探讨征聘和留住黑人的其他办法。 美国参与者利用数字评估进行AD/ADRD研究。美国黑人 在FHS队列中代表性不足,主要是非西班牙裔白色。参与者自我- 被认为是黑人的人只占FHS队列的1.7%,而他们占米德尔塞克斯的5.2%。 国家,其中包括弗拉芒镇和周边社区;这是低于什么是 在马萨诸塞州,黑人占总人口的9.3%。 AD/ADRD对美国黑人的影响率高于非西班牙裔白人,这使得必须 他们被纳入研究,但招募工作的成功有限。一个被广泛描述的因素 使招募美国黑人具有挑战性的是对科学研究缺乏信任, 美国政府和科学家对这一群体的历史虐待,因此我们将重点放在 培养对我们方法的信任。我们打算与两位黑人社区参与专家合作, 促进我们的努力。我们的第一个目标是与当地黑人领袖建立联系, 了解社区的需求,以及我们如何为这些需求做出贡献,这样我们就可以培养信任, 合作设计有效的招聘/保留协议。第二个目标是执行和 通过征求社区的反馈来评估这个新开发的招募/保留协议 方案获得成功的成员(增加了了解研究的兴趣)以及 《议定书》没有促进其参与兴趣的国家也是如此。我们将根据 根据这些反馈,采用修订后的程序,并重新评估。第三个目标是问那些谁 表示有兴趣了解更多关于我们的研究,以评估数字数据收集协议, 就他们愿意做哪些部分,不愿意做哪些部分给出反馈。于其后向业主悉数 邀请参加我们的数字数据收集研究,以增加美国黑人的代表性。我们 预计将从119-314名美国黑人参与者中收集数字数据。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Redefining and Validating Digital Biomarkers as Fluid, Dynamic Multi-Dimensional Digital Signal Patterns.
  • DOI:
    10.3389/fdgth.2021.751629
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Au R;Kolachalama VB;Paschalidis IC
  • 通讯作者:
    Paschalidis IC
Alzheimer's disease amyloid-β pathology in the lens of the eye.
  • DOI:
    10.1016/j.exer.2022.108974
  • 发表时间:
    2022-08
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Moncaster, Juliet A.;Moir, Robert D.;Burton, Mark A.;Chadwick, Oliver;Minaeva, Olga;Alvarez, Victor E.;Ericsson, Maria;Clark, John I.;McKee, Ann C.;Tanzi, Rudolph E.;Goldstein, Lee E.
  • 通讯作者:
    Goldstein, Lee E.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rhoda Au其他文献

Rhoda Au的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rhoda Au', 18)}}的其他基金

Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测
  • 批准号:
    10625625
  • 财政年份:
    2021
  • 资助金额:
    $ 25.18万
  • 项目类别:
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测
  • 批准号:
    10214162
  • 财政年份:
    2021
  • 资助金额:
    $ 25.18万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10670323
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
  • 批准号:
    10670318
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk
阿尔茨海默病高风险人群的认知异质性
  • 批准号:
    9975371
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk
阿尔茨海默病高风险人群的认知异质性
  • 批准号:
    10404703
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
  • 批准号:
    10468279
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10256770
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
  • 批准号:
    10256768
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10047355
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了